These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9083278)

  • 1. Characterization of C3 receptors on cultured rat glomerular endothelial cells.
    Alexander JJ; He C; Adler S; Holers VM; Quigg RJ
    Kidney Int; 1997 Apr; 51(4):1124-32. PubMed ID: 9083278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of C3-binding proteins on mouse neutrophils and platelets.
    Quigg RJ; Alexander JJ; Lo CF; Lim A; He C; Holers VM
    J Immunol; 1997 Sep; 159(5):2438-44. PubMed ID: 9278336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of rat complement receptors and regulatory proteins. CR2 and Crry are conserved, and the C3b receptor of neutrophils and platelets is distinct from CR1.
    Quigg RJ; Holers VM
    J Immunol; 1995 Aug; 155(3):1481-8. PubMed ID: 7636211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand specificities of mouse complement receptor types 1 (CR1) and 2 (CR2) purified from spleen cells.
    Pramoonjago P; Takeda J; Kim YU; Inoue K; Kinoshita T
    Int Immunol; 1993 Apr; 5(4):337-43. PubMed ID: 7684250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of rat glomerular epithelial cell complement receptors.
    Quigg RJ; Sneed AE
    J Am Soc Nephrol; 1994 May; 4(11):1912-9. PubMed ID: 7919144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the human glomerular C3 receptor as the C3b/C4b complement type one (CR1) receptor.
    Fischer E; Appay MD; Cook J; Kazatchkine MD
    J Immunol; 1986 Feb; 136(4):1373-7. PubMed ID: 2418113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the EBV/C3d receptor on the human Jurkat T cell line: evidence for a novel transcript.
    Sinha SK; Todd SC; Hedrick JA; Speiser CL; Lambris JD; Tsoukas CD
    J Immunol; 1993 Jun; 150(12):5311-20. PubMed ID: 8390533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for three binding sites for C3 (hemolytically inactive), C3b and C3d on a CR2-positive Burkitt lymphoma-derived cell line (Raji).
    Barile G; Di Renzo L; Lipari M; Frati L; Faggioni A
    FEBS Lett; 1993 Jun; 324(3):319-24. PubMed ID: 8405374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement regulation in the rat glomerulus: Crry and CD59 regulate complement in glomerular mesangial and endothelial cells.
    Quigg RJ; Morgan BP; Holers VM; Adler S; Sneed AE; Lo CF
    Kidney Int; 1995 Aug; 48(2):412-21. PubMed ID: 7564108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration and characterization of C3 receptors on rat glomerular epithelial cells.
    Kasinath BS; Maaba MR; Schwartz MM; Lewis EJ
    Kidney Int; 1986 Dec; 30(6):852-61. PubMed ID: 2950268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of complement C3 receptors on human astrocytes.
    Gasque P; Chan P; Mauger C; Schouft MT; Singhrao S; Dierich MP; Morgan BP; Fontaine M
    J Immunol; 1996 Mar; 156(6):2247-55. PubMed ID: 8690915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histochemical contributions to the binding mechanism of complement (CR1, CR2) receptors.
    Baranyay F
    Pathol Oncol Res; 2009 Dec; 15(4):639-44. PubMed ID: 19353305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteins.
    Weis JJ; Toothaker LE; Smith JA; Weis JH; Fearon DT
    J Exp Med; 1988 Mar; 167(3):1047-66. PubMed ID: 2832506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for multiple sites of interaction in C3 for complement receptor type 2 (C3d/EBV receptor, CD21).
    Esparza I; Becherer JD; Alsenz J; De la Hera A; Lao Z; Tsoukas CD; Lambris JD
    Eur J Immunol; 1991 Nov; 21(11):2829-38. PubMed ID: 1834472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A complement C3 fragment equivalent to mammalian C3d from the common carp (Cyprinus carpio): generation in serum after activation of the alternative pathway and detection of its receptor on the lymphocyte surface.
    Nakao M; Miura C; Itoh S; Nakahara M; Okumura K; Mutsuro J; Yano T
    Fish Shellfish Immunol; 2004 Feb; 16(2):139-49. PubMed ID: 15123318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complement.
    Weis JJ; Fearon DT; Klickstein LB; Wong WW; Richards SA; de Bruyn Kops A; Smith JA; Weis JH
    Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5639-43. PubMed ID: 3016712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic analysis of the interactions of complement receptor 2 (CR2, CD21) with its ligands C3d, iC3b, and the EBV glycoprotein gp350/220.
    Sarrias MR; Franchini S; Canziani G; Argyropoulos E; Moore WT; Sahu A; Lambris JD
    J Immunol; 2001 Aug; 167(3):1490-9. PubMed ID: 11466369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analyses reveal that the staphylococcal immune evasion molecule Sbi and complement receptor 2 (CR2) share overlapping contact residues on C3d: implications for the controversy regarding the CR2/C3d cocrystal structure.
    Isenman DE; Leung E; Mackay JD; Bagby S; van den Elsen JM
    J Immunol; 2010 Feb; 184(4):1946-55. PubMed ID: 20083651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of C3b/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2.
    Molina H; Kinoshita T; Webster CB; Holers VM
    J Immunol; 1994 Jul; 153(2):789-95. PubMed ID: 8021513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope mapping using the X-ray crystallographic structure of complement receptor type 2 (CR2)/CD21: identification of a highly inhibitory monoclonal antibody that directly recognizes the CR2-C3d interface.
    Guthridge JM; Young K; Gipson MG; Sarrias MR; Szakonyi G; Chen XS; Malaspina A; Donoghue E; James JA; Lambris JD; Moir SA; Perkins SJ; Holers VM
    J Immunol; 2001 Nov; 167(10):5758-66. PubMed ID: 11698449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.